Asian markets ended higher on Thursday amid renewed optimism over a potential Brexit deal and ahead of the Christmas holiday, even after US President Donald Trump's threat to veto the stimulus bill. Moreover, Covid-19 vaccine rollout also buoyed expectations of global economic recovery from the pandemic. Seoul shares ended up after South Korea signed deals with Pfizer Inc and Johnson & Johnson's Janssen to import corona virus vaccines to cover up to 16 million people. Though, Chinese shares declined on reports of an antitrust investigation into Alibaba, the country’s biggest tech company, a month after authorities halted sister company Ant Group’s $37 billion initial public offering.
Asian Indices | Last Trade | Change in Points | Change in % |
Shanghai Composite | 3,363.11 | -19.21 | -0.57 |
Hang Seng | 26,386.56 | 43.46 | 0.16 |
Jakarta Composite | - | - | - |
KLSE Composite | 1,641.17 | -6.33 | -0.38 |
Nikkei 225 | 26,668.35 | 143.56 | 0.54 |
Straits Times | 2,842.04 | 8.64 | 0.30 |
KOSPI Composite | 2,806.86 | 47.04 | 1.70 |
Taiwan Weighted | 14,280.28 | 57.19 | 0.40 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: